Goldman Sachs’s Natus Medical Inc NTUS Stock Holding History

Goldman Sachs’s Portfolio NTUS Stock Details NTUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-29,800	Closed	-$766K	–	5464
2019 Q2	$766K	Buy	+29,800	New	+$759K	﹤0.01%	4160
2014 Q4	–	Sell	-286,300	Closed	-$8.45M	–	7381
2014 Q3	$8.45M	Sell	286,300 -494,200	-63%	-$13.6M	﹤0.01%	2502
2014 Q2	$19.6M	Sell	780,500 -299,100	-28%	-$7.4M	0.01%	1793
2014 Q1	$27.9M	Buy	1,079,600 +821,900	+319%	+$20.7M	0.01%	1497
2013 Q4	$5.8M	Buy	+257,700	New	+$4.98M	﹤0.01%	2912

Other funds holding NTUS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Goldman Sachs's NTUS Position: Q3 2022 in Review

Goldman Sachs sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 294,571 shares — an estimated $9.65M sold.

Goldman Sachs first reported a position in NTUS in Q2 2013 and held it in 37 quarters. The position peaked at $17.5M in Q2 2021. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.

Goldman Sachs reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
Goldman Sachs sold 294,571 Natus Medical Inc shares in Q3 2022, an estimated $9.65M.
Goldman Sachs first reported a position in Natus Medical Inc in Q2 2013 and held it in 37 quarters.
Goldman Sachs's Natus Medical Inc position peaked at $17.5M in Q2 2021.
1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.

Based on Goldman Sachs's 13F filing for Q3 2022, filed 14 Nov 2022.